Frederick T. Muto - 15 Jun 2021 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Frederick T. Muto
Issuer symbol
IONS
Transactions as of
15 Jun 2021
Net transactions value
-$410,000
Form type
4
Filing time
17 Jun 2021, 17:05:01 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $46,500 +5,000 +16% $9.30* 36,683 15 Jun 2021 Direct F1
transaction IONS Common Stock Sale $182,500 -5,000 -14% $36.50 31,683 15 Jun 2021 Direct F2
transaction IONS Common Stock Options Exercise $46,500 +5,000 +16% $9.30* 36,683 15 Jun 2021 Direct F1
transaction IONS Common Stock Sale $182,750 -5,000 -14% $36.55 31,683 15 Jun 2021 Direct F2
transaction IONS Common Stock Options Exercise $46,500 +5,000 +16% $9.30* 36,683 15 Jun 2021 Direct F1
transaction IONS Common Stock Sale $184,250 -5,000 -14% $36.85 31,683 15 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -33% $0.000000 10,000 15 Jun 2021 Common Stock 5,000 $9.30 Direct
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -50% $0.000000 5,000 15 Jun 2021 Common Stock 5,000 $9.30 Direct
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -5,000 -100% $0.000000* 0 15 Jun 2021 Common Stock 5,000 $9.30 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
F2 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.